Cite Filings / ARWR / 0001564590-21-004319
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

ARROWHEAD PHARMACEUTICALS, INC. · Filed 2021-02-04 · Acc 0001564590-21-004319

Documents 1

  • 10-Q Quarterly Report , arwr-10q_20201231.htm

Around this filing

  • 2021-05-04 10-Q Quarterly Report
  • 2021-02-10 4 General Counsel sold 90,000 shares at an average $88.46 ($7,961,240)
  • 2021-02-10 SC 13G/A Amended Statement of Ownership
  • 2021-02-05 CORRESP Correspondence Between Filers and SEC Staff
  • 2021-02-04 10-Q Quarterly Report
  • 2021-02-04 8-K Results of operations
  • 2020-08-05 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading arwr-10q_20201231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…